| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 2513242 | Biochemical Pharmacology | 2010 | 8 Pages | 
Abstract
												Phospholipases A2 (PLA2s) form a family of enzymes catalyzing the hydrolysis of membrane phospholipids into arachidonic acid, which is the major precursor of pro-inflammatory eicosanoids. As a result, PLA2s have been considered as potential targets in anti-inflammatory drug discovery.Marine natural products are a rich source of bioactive compounds, including PLA2 inhibitors. Here, we review the properties of marine PLA2 inhibitors identified since the first discovery of PLA2 inhibitory activity in the marine natural product manoalide in the mid 1980s.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
												
											Related Topics
												
													Health Sciences
													Pharmacology, Toxicology and Pharmaceutical Science
													Pharmacology
												
											Authors
												Florence Folmer, Marcel Jaspars, Marc Schumacher, Mario Dicato, Marc Diederich, 
											